| May 8-10, 1998
Saint Louis, Missouri
The
published proceedings of the 21st Princeton Conference are now available.
Cerebrovascular Disease: Momentum at the
End of the Second Millennium
Editors: Dennis Choi, Ralph Dacey, Chung Hsu, William Powers
Blackwell Publishing (February 2002)
Medirect
| Amazon
Friday,
May 8, 1998 |
Welcome
Dennis W. Choi, MD, PhD |
|
NIH/NINDS challenge: New opportunities and initiatives
Gerald D. Fischbach MD, and Michael D. Walker, MD |
|
Extracranial-intracranial bypass surgery: Time for a new clinical
trial?
Chairs: Ralph G. Dacey Jr. and William J. Powers
|
|
Mediators and modulators of ischemic injury: Hot topics
Chairs: Richard J. Traystman and Peter Lipton
|
|
White matter ischemia - unique mechanisms of injury?
Chairs: Mark P. Goldberg and Vladimir Hachinski
|
|
Inflammation
Chairs: John M. Hallenbeck and Michael Chopp
|
|
Plenary lecture:
Free radicals and ischemic brain injury
Bo K. Siesjo, MD, PhD
|
Dinner Debate:
Heparin should be used to treat patients presenting with acute stroke
or stroke-in-evolution
Moderator: Michael N. Diringer, MD
|
|
|
Saturday, May 9,
1998 |
Beyond diffusion: imaging measurements of cerebral blood flow and
metabolism
Chairs: Marc Fisher and Justin A. Zivin
|
|
Molecular mechanisms of apoptosis
Chairs: Matthew D. Linnik and Michael A. Moskowitz
|
|
Delayed neuronal death
Chairs: William A. Pulsinelli and Myron D. Ginsberg
|
|
Cortical reorganization and post-acute stroke treatment
Chairs: Larry B. Goldstein and Alexander W. Dromerick
|
|
Update: Recent Clinical Trials of Drug Treatments for Stroke
Greg Albers, MD
|
Plenary lecture:
CNS Stem cells: Biology and potential utility for promoting recovery
Fred H. Gage, PhD
|
Dinner Debate:
MRI is a good endpoint for determining the efficacy of stroke treatment
trials
Moderator: Edward M. Manno, MD
|
|
|
Sunday, May 10, 1998
|
Directions for the future: where should we go?
Moderators: Dennis W. Choi and Murray Goldstein, DO, MPH)
|
|
Princeton Conference
Home Page |